Brian R Barrows1, Elizabeth J Parks. 1. Center for Human Nutrition, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75390-9052, USA.
Abstract
CONTEXT: The liver's regulation of fatty acids (FAs) postprandially may contribute to risk of metabolic diseases. OBJECTIVE: Measurements of steady-state metabolism were used to investigate sources of FAs used for very low-density lipoprotein (VLDL)-triacylglycerol (TG) synthesis during fasting and feeding in vivo. DESIGN/INTERVENTION: Subjects were duodenally fed a formula labeled with the stable isotope glyceryl tri-palmitate-d(31) and iv infused with [1,2,3,4-(13)C(4)]-palmitatic acid and [1-(13)C(1)]-acetate to quantitate the liver's use of FAs originating from adipose tissue and de novo lipogenesis. SETTING/PARTICIPANTS: This study of healthy men (n = 12; body mass index, 24.4 +/- 2.7 kg/m(2)) was conducted at a General Clinical Research Center. MAIN OUTCOME MEASURES: Concentrations of metabolites during fasting and feeding, sources of FAs used for lipoprotein synthesis, rate of appearance of serum nonesterified FA (NEFA), and VLDL-TG were measured. RESULTS: During fasting, 77.2 +/- 14.0% of VLDL-TG was derived from adipose FA recycling and 4.0 +/- 3.6% from lipogenesis; with feeding, 43.6 +/- 18.6% came from adipose FAs (P < 0.001), 8.2 +/- 5.1% from lipogenesis (P < 0.001), 15.2 +/- 13.7% from uptake of chylomicron-remnant TG, and 10.3 +/- 6.9% from dietary FA spillover into the serum NEFA pool. Fed-state VLDL-TG from NEFA reesterification decreased in proportion to the reduction in adipose NEFA appearance. CONCLUSION: These data: 1) quantify the extent to which the healthy liver manages its use of different sources of FAs that flow to it, 2) demonstrate how the postprandial reduction in adipose-NEFA flux may be partially replaced by other sources, and 3) highlight the potential for dietary FA spillover to support the continued dominance of NEFA as a substrate for VLDL-TG synthesis.
CONTEXT: The liver's regulation of fatty acids (FAs) postprandially may contribute to risk of metabolic diseases. OBJECTIVE: Measurements of steady-state metabolism were used to investigate sources of FAs used for very low-density lipoprotein (VLDL)-triacylglycerol (TG) synthesis during fasting and feeding in vivo. DESIGN/INTERVENTION: Subjects were duodenally fed a formula labeled with the stable isotope glyceryl tri-palmitate-d(31) and iv infused with [1,2,3,4-(13)C(4)]-palmitatic acid and [1-(13)C(1)]-acetate to quantitate the liver's use of FAs originating from adipose tissue and de novo lipogenesis. SETTING/PARTICIPANTS: This study of healthy men (n = 12; body mass index, 24.4 +/- 2.7 kg/m(2)) was conducted at a General Clinical Research Center. MAIN OUTCOME MEASURES: Concentrations of metabolites during fasting and feeding, sources of FAs used for lipoprotein synthesis, rate of appearance of serum nonesterified FA (NEFA), and VLDL-TG were measured. RESULTS: During fasting, 77.2 +/- 14.0% of VLDL-TG was derived from adipose FA recycling and 4.0 +/- 3.6% from lipogenesis; with feeding, 43.6 +/- 18.6% came from adipose FAs (P < 0.001), 8.2 +/- 5.1% from lipogenesis (P < 0.001), 15.2 +/- 13.7% from uptake of chylomicron-remnant TG, and 10.3 +/- 6.9% from dietary FA spillover into the serum NEFA pool. Fed-state VLDL-TG from NEFA reesterification decreased in proportion to the reduction in adipose NEFA appearance. CONCLUSION: These data: 1) quantify the extent to which the healthy liver manages its use of different sources of FAs that flow to it, 2) demonstrate how the postprandial reduction in adipose-NEFA flux may be partially replaced by other sources, and 3) highlight the potential for dietary FA spillover to support the continued dominance of NEFA as a substrate for VLDL-TG synthesis.
Authors: Maria A Ramos-Roman; Smadar A Lapidot; Robert D Phair; Elizabeth J Parks Journal: Arterioscler Thromb Vasc Biol Date: 2012-06-21 Impact factor: 8.311
Authors: Daniel F Vatner; Sachin K Majumdar; Naoki Kumashiro; Max C Petersen; Yasmeen Rahimi; Arijeet K Gattu; Mitchell Bears; João-Paulo G Camporez; Gary W Cline; Michael J Jurczak; Varman T Samuel; Gerald I Shulman Journal: Proc Natl Acad Sci U S A Date: 2015-01-06 Impact factor: 11.205
Authors: Haojie Yu; Antoine Rimbert; Alice E Palmer; Takafumi Toyohara; Yulei Xia; Fang Xia; Leonardo M R Ferreira; Zhifen Chen; Tao Chen; Natalia Loaiza; Nathaniel Brooks Horwitz; Michael C Kacergis; Liping Zhao; Alexander A Soukas; Jan Albert Kuivenhoven; Sekar Kathiresan; Chad A Cowan Journal: Cell Date: 2019-11-27 Impact factor: 41.582
Authors: Luke W Johnston; Stewart B Harris; Ravi Retnakaran; Adria Giacca; Zhen Liu; Richard P Bazinet; Anthony J Hanley Journal: Diabetologia Date: 2017-12-24 Impact factor: 10.122
Authors: Leanne Hodson; Siobhán E McQuaid; Sandy M Humphreys; Ross Milne; Barbara A Fielding; Keith N Frayn; Fredrik Karpe Journal: Am J Physiol Endocrinol Metab Date: 2010-07-13 Impact factor: 4.310
Authors: Jennifer M Rojas; John M Stafford; Sanaz Saadat; Richard L Printz; Annette G Beck-Sickinger; Kevin D Niswender Journal: Am J Physiol Endocrinol Metab Date: 2012-10-16 Impact factor: 4.310